The Role of c-Met as a Biomarker and Player in Innate and Acquired Resistance in Non-Small-Cell Lung Cancer: Two New Mutations Warrant Further Studies.

Molecules · 2019 · PMC6943481 · PMID 31817278

Europe PMC DOI

hedged sentences

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

showed a trendp = 0.058so close (0.05 < p ≤ 0.1)

E168D and S203T mutations showed a trend towards a correlation with high c-Met expression ( p = 0.058).

also in 53,322 other papers

a strong trendp = 0.058so close (0.05 < p ≤ 0.1)

When comparing the different mutations separately, there was a strong trend ( p = 0.058) towards an association between two c-Met mutations and c-Met expression.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.